Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): Use of biologically active labeled MIF derivatives

被引:32
作者
Kleemann, R
Grell, M
Mishcke, R
Zimmermann, G
Bernhagen, J
机构
[1] Univ Stuttgart, Inst Interfacial Engn, Biochem Lab, D-70569 Stuttgart, Germany
[2] TNO PG, Gaubius Lab, NL-2301 CE Leiden, Netherlands
[3] Merck KGaA, Preclin Res Oncol, D-64287 Darmstadt, Germany
[4] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany
关键词
D O I
10.1089/107999002753675785
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine for which a receptor has not been identified. That MIF has intracellular functions has been suggested by its enzymatic activity and constitutive expression profile. The discovery of functional MIF-c-Jun activation domain binding protein 1 (JAB1) binding has confirmed this notion and indicated that nonreceptor-based signaling mechanisms are important for MIF function. Here, we have generated and tested several biologically active labeled MIF derivatives to further define target protein binding by MIF and its cellular uptake characteristics. S-35-MIF, biotinylated MIF, and fluoresceinated MIF were demonstrated to exhibit full biologic activity. Neither by applying a standard iodinated MIF preparation nor by using the biologically active S-35-MIF derivative in receptor-binding studies were we able to measure any receptor-binding activity on numerous cells, confirming that uptake of MIF into target cells and MIF signaling can occur by receptor-independent pathways. When MIF derivatives were applied in cellular uptake studies, MIF was found to be endocytosed into both immune and nonimmune cells and targeted to the cytosol and lysosomes. The entry of MIF was temperature and energy dependent and was inhibited by monodansylcadaverine but not by ouabain. Endocytosed biotin-MIF bound JAB1 not only in macrophages, as shown previously, but also in nonimmune cells. A tagged MIF construct, MIF-enhanced green fluorescent protein (EGFP), was shown to be a valuable tool, as EGFP constructs of critical MIF cysteine mutants exhibited identical cellular localization properties to those of wild-type MIF (wtMIF). Our results indicate that MIF membrane receptors are not widely expressed, if at all, and suggest that the cellular uptake of MIF occurs by nonreceptor-mediated endocytosis rather than penetration. All the derivatives investigated, except for iodinated MIF, represent valuable tools for further MIF target protein and cellular studies.
引用
收藏
页码:351 / 363
页数:13
相关论文
共 64 条
  • [1] Regulation of the CTL response by macrophage migration inhibitory factor
    Abe, R
    Peng, T
    Sailors, J
    Bucala, R
    Metz, CN
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (02) : 747 - 753
  • [2] The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes
    Acosta, JA
    Benzaquen, LR
    Goldstein, DJ
    Tosteson, MT
    Halperin, JA
    [J]. MOLECULAR MEDICINE, 1996, 2 (06) : 755 - 765
  • [3] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [4] Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor
    Bendrat, K
    AlAbed, Y
    Callaway, DJE
    Peng, T
    Calandra, T
    Metz, CN
    Bucala, R
    [J]. BIOCHEMISTRY, 1997, 36 (49) : 15356 - 15362
  • [5] Bennett GL, 1997, METHOD ENZYMOL, V288, P134
  • [6] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [7] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF)
    BERNHAGEN, J
    MITCHELL, RA
    CALANDRA, T
    VOELTER, W
    CERAMI, A
    BUCALA, R
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14144 - 14155
  • [8] Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features
    Bernhagen, J
    Calandra, T
    Bucala, R
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4): : 151 - 161
  • [9] An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
    Bernhagen, J
    Bacher, M
    Calandra, T
    Metz, CN
    Doty, SB
    Donnelly, T
    Bucala, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 277 - 282
  • [10] Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
    Bozza, M
    Satoskar, AR
    Lin, GS
    Lu, B
    Humbles, AA
    Gerard, C
    David, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 341 - 346